| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Departments of Pathology, Internal Medicine "B," Bacteriology and Clinical Research, Hebrew University-Hadassah Medical School, Jerusalem, Israel)
The uptake of parenterally administered B12-Co60 and the vitamin B12 content were studied in rats bearing liver tumors induced by DAB.
The specific activity of B12-Co60 of the serum showed a decline during the 1st week, but was still much higher than that of either liver or tumor tissue 7 days following injection.
The B12-Co60 uptakes of the liver and tumor tissue were similar during the first 48 hours; at 7 and 12 days an increase of B12-Co60 concentration was found in the liver, but not in the tumor tissue. In contrast to the liver the B12-Co60 concentration in the kidney showed a decline with increasing time intervals following injection.
The total B12 content of the tumors, as determined by microbiological assay, was about one-fifth of that of the non-neoplastic part of the liver.
* This investigation was supported by Leukemia Research Foundation, Chicago, Ill.
Received 2/26/58.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |